SAN DIEGO–(HSMN NewsFeed)–La Jolla Clinical Company (Pink Sheets: LJPC ) today announced that La Jolla and Adamis Pharmaceuticals Corporation (OTCBB: ADMP ) have agreed to terminate their merger agreement relating to the proposed merger of the 2 …
Biopharmaceuticals, Mergers & Acquisitions
La Jolla Laboratory, Adamis Pharmaceuticals

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “La Jolla Pharmaceutical Announces Termination of Merger Agreement with Adamis Pharmaceuticals”
Leave a Comment